Sign in
4

Changes in Ownership

VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-26-000112

EVP, Chief Scientific Officer sold 620 shares at $486.35 ($301,537)

  • EVP, Chief Scientific Officer gave up 582 shares (to pay taxes)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Bunnage Mark E. · EVP, Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-02-24 Shares withheld for taxes : show line 1 in the form 10b5-1 −582 $485.11 $282,334 7,904 D
2026-02-25 Sale : show line 2 in the form 10b5-1 −620 $486.35 $301,537 7,284 D
Open-market sales · 620 sh · avg $486.35 · $301,537
Loading xslF345X05/wk-form4_1772147216.xml…